Statistics
Total Visits
| Views | |
|---|---|
| HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 97 |
Total Visits Per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 7 | 11 | 0 | 4 | 5 | 13 | 0 |
File Visits
| Views | |
|---|---|
| Warren-Rachel-MSc-CH&E-August-2020.pdf | 309 |
Top country views
| Views | |
|---|---|
| United States | 60 |
| China | 8 |
| Canada | 5 |
| Vietnam | 5 |
| Ireland | 4 |
| Bulgaria | 2 |
| Sweden | 2 |
| Australia | 1 |
| Ethiopia | 1 |
| Indonesia | 1 |
Top cities views
| Views | |
|---|---|
| Blue Bell | 11 |
| Houston | 9 |
| Oakland | 8 |
| Wilmington | 6 |
| Fairfield | 5 |
| Hanoi | 5 |
| Dublin | 4 |
| Fuzhou | 3 |
| Menlo Park | 3 |
| Palo Alto | 3 |